FORMULATION OPTIMIZATION AND CHARACTERIZATION OF AQUEOUS INJECTION CONTAINING POORLY SOLUBLE DRUG USING MIXED HYDROTROPIC SOLUBILIZATION

NEELKUMAR K. DARAJI; VIPUL P. PATEL; VINODKUMAR D. RAMANI

doi:10.22159/ijcpr.2021v13i5.1908

Authors

NEELKUMAR K. DARAJI Pharmacy Department, Hemchandracharya North Gujarat University, Patan, Gujarat, India
VIPUL P. PATEL Sanjivani College of Pharmaceutical Education and Research, Kopargaon, Maharashtra, India
VINODKUMAR D. RAMANI Bhagwan Mahavir College of Pharmacy, Bhagwan Mahavir University, Surat, Gujarat, India

DOI:

https://doi.org/10.22159/ijcpr.2021v13i5.1908

Keywords:

Mixed solvency, Mefenamic acid, Solubility, Aqueous injection, Hydrotropy, Hydrotrops

Abstract

Objective: Mefenamic acid (MFA) is an NSAID that exhibits anti-inflammatory analgesic and antipyretic activity. Peak plasma levels are attained in 2-4 h and the elimination half-life approximates 2 h, repetitive administration of tablets for 3-5 times a day is desired. It is supplied only in the form of tablets for oral administration. In acute conditions drug administered parenterally could give rapid relief from severe symptoms like pain. Thus, formulation of injectable formulation of MFA could be better alternative compared to conventional tablet dosage form. The low aqueous solubility of MFA precludes its use in parenteral formulation development.

Methods: In this work attempt were made to enhance the aqueous solubility of mefenamic acid using mixed solvency technique. For that different hydrotropic agents such as Urea, Sodium acetate, sodium benzoate, sodium citrate and their blends were evaluated. Optimal concentration of hydrotropic agent in blend was determined using D-optimal mixture experimental design. The optimized bled was used to develop the aqueous injection of mefenamic acid. The developed injection was subjected for various quality control tests and stability of developed formulation was also evaluated.

Results: The aqueous solubility in optimized blend of hydrotropic agent batches (U: SA: SB: SC, 4:4:23:9 %w/v) showed 835.71-fold compared to MFA solubility in distilled water. The quality control tests for parenteral formulation and accelerated stability study were found to be within prescribed limits and stable.

Conclusion: The inadequate solubility of MFA was overcome, and aqueous injection was successfully developed which can be serve as cost effective treatment in various indications.

Downloads

Download data is not yet available.

References

Zhou Y, Du J, Wang L, Wang Y. Nanocrystals technology for improving bioavailability of poorly soluble drugs: A mini-review. J Nanosci Nanotechnol. 2017;17(1):18-28. doi: 10.1166/jnn.2017.13108, PMID 29616786.

Patil PB, Gupta V, Udupi R, Srikanth K, Prasad B. Development of dissolution medium for poorly water-soluble drug mefenamic acid. Res J Pharm Biol Chem. 2010;1:544-9.

TenHoor CN, Bakatselou V, Dressman J. Solubility of mefenamic acid under simulated fed- and fasted-state conditions. Pharm Res. 1991;8(9):1203-5. doi: 10.1023/a:1015874906665, PMID 1788169.

Kumar M, Singh D, Bedi N. Mefenamic acid-loaded solid SMEDDS: an innovative aspect for dose reduction and improved pharmacodynamic profile. Ther Deliv. 2019;10(1):21-36. doi: 10.4155/tde-2018-0053, PMID 30730824.

Sriamornsak P, Limmatvapirat S, Piriyaprasarth S, Mansukmanee P, Huang Z. A new self-emulsifying formulation of mefenamic acid with enhanced drug dissolution. Asian J Pharm Sci. 2015;10(2):121-7. doi: 10.1016/j.ajps.2014.10.003.

Sid D, Baitiche M, Elbahri Z, Djerboua F, Boutahala M, Bouaziz Z, Le Borgne M. Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies. J Enzyme Inhib Med Chem. 2021;36(1):605-17. doi: 10.1080/14756366.2020.1869225, PMID 33557644.

Maheshwari R. Mixed hydrotropy in spectrophotometric analysis of aceclofenac. Indian Pharm. 2007;6:67-9.

Etman M, Salama R, Shamsedeen M, El-Kamel A. Solubilization of etodolac for parenteral administration. Indian J Pharm Sci. 2001;63:459.

Poochikian GK, Cradock JC. Enhanced chartreusin solubility by hydroxybenzoate hydrotropy. J Pharm Sci. 1979;68(6):728-32. doi: 10.1002/jps.2600680620, PMID 458574.

Maheshwari R. Potentiation of solvent character by mixed solvency concept: A novel concept of solubilization. J Pharm Res. 2010;3:411-3.

Maheshwari R, Shilpkar R. Formulation development and evaluation of injection of poorly soluble drug using mixed solvency concept. Int J Pharm Biol Sci. 2012;3.

Armstrong NA, James KC. Pharmaceutical experimental design and interpretation. CRC Press; 2002.

Adinarayana K, Ellaiah P. Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp. J Pharm Pharm Sci. 2002;5(3):272-8. PMID 12553896.

Ahnazarova SL, Kafarov VV. Rep’ev AP. Experiment optimization in chemistry and chemical engineering. Moscow and Chicago: MIR Publishers; 1982.

Borror CM, Montgomery DC, Myers RH. Evaluation of statistical designs for experiments involving noise variables. J Qual Technol. 2002;34(1):54-70. doi: 10.1080/00224065. 2002. 11980129.

Stranz M, Kastango ES. A review of pH and osmolarity. Int J Pharm Compd. 2002;6(3):216-20. PMID 23979188.

Shi Y, Porter W, Merdan T, Li LC. Recent advances in intravenous delivery of poorly water-soluble compounds. Expert Opin Drug Deliv. 2009;6(12):1261-82. doi: 10.1517/17425240903307423, PMID 19941409.